Embolization Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 1

Embolization General Information

Description

Developer of radiopaque polymer-based medical devices intended to confirm procedural success in vascular treatments. The company's platform utilizes shape-memory biocompatible polymer technology, achieving superior vascular occlusion and minimizing imaging artifacts often seen with traditional metal devices, which enables interventional radiologists treating peripheral and neurovascular conditions to experience benefits such as shorter occlusion times, tighter coil packs, the use of fewer devices per procedure, and reduced recanalization rates, enabling patients with outcomes and lower manufacturing costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5421 Western Avenue
  • Boulder, CO 80301
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 5421 Western Avenue
  • Boulder, CO 80301
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Embolization Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 18-Jul-2023 Completed Product Development
To view Embolization’s complete valuation and funding history, request access »

Embolization Patents

Embolization Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200383689-A1 Systems, devices and methods for improved occlusion and delivery Inactive 05-Jun-2019
US-12734255-B2 Radiopaque polymers with enhanced radiopacity Active 02-Dec-2016
US-20200054770-A1 Radiopaque polymers with enhanced radiopacity Active 02-Dec-2016
US-11389170-B2 Occlusive implants with fiber-based release structures Active 16-Sep-2016
US-12167854-B2 Occlusive implants with fiber-based release structures Active 16-Sep-2016 A61B17/12113
To view Embolization’s complete patent history, request access »

Embolization Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Volcano Capital Venture Capital Minority
To view Embolization’s complete investors history, request access »

Embolization FAQs

  • When was Embolization founded?

    Embolization was founded in 2023.

  • Where is Embolization headquartered?

    Embolization is headquartered in Boulder, CO.

  • What industry is Embolization in?

    Embolization’s primary industry is Therapeutic Devices.

  • Is Embolization a private or public company?

    Embolization is a Private company.

  • What is Embolization’s current revenue?

    The current revenue for Embolization is .

  • Who are Embolization’s investors?

    Volcano Capital has invested in Embolization.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process